Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Credit agrmnt [a]
CNL Healthcare Properties, Inc. (CHTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/17/2023 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
07/10/2023 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
06/16/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
06/06/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits...
Docs: "Fourth Amendment to Advisory Agreement by and among the Company, Operating Partnership and Advisor dated effective as of June 8, 2023"
05/15/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/04/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "31, 2022, 2021, 2020, 2019",
"CHP 2022 Valuation Webinar Script"
03/13/2023 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
03/10/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Text of correspondence from the Company to Stockholders regarding the 2022 NAV",
"Text of correspondence from the Company to Financial Professionals regarding the 2022 NAV"
02/28/2023 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
01/24/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Text of correspondence to financial professionals and broker dealers",
"Text of correspondence to financial professionals and broker dealers"
12/07/2022 8-K Quarterly results
11/23/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/25/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/26/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
09/08/2022 8-K Credit agreement amendment
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Term Loan Second Amendment",
"Credit Agreement Second Amendment"
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/27/2022 3 MCRAE JOHN R. (Senior Vice President) has filed a Form 3 on CNL Healthcare Properties, Inc.
07/22/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/30/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Webinar presentation related to Company’s 2021 NAV",
"Webinar script related to Company’s 2021 NAV"
03/23/2022 10-K Annual Report for the period ended December 31, 2021
03/22/2022 8-K Credit agreement amendment
Docs: "First Amendment to Term Loan Agreement",
"First Amendment to Credit Agreement",
"Text of correspondence from the Company to Stockholders regarding the 2021 NAV",
"Text of correspondence from the Company to Financial Professionals regarding the 2021 NAV"
03/15/2022 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/03/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
02/16/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
01/10/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy